Photo by Myriam Zilles on Unsplash
Beijing Sinotau International Pharmaceutical Technology (Sinotau) has secured over 1.1 billion yuan ($151.8 million) in a new funding round to advance the R&D and clinical trials of its radiopharmaceutical pipeline, the firm announced on Monday.
